As of 30 Sep 2025, 0 institutional investors reported holding $0 in principal (par value) of PACIRA BIOSCIENCES INC - NOTE 0.750% 8/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $0 | $0 | -$194,579,103 | 0 | |
| 2025 Q2 | $196,560,000 | $195,465,748 | -$2,267,489 | 99.38% | 32 |
| 2025 Q1 | $198,558,000 | $195,647,245 | +$781,732 | 98.38% | 32 |
| 2024 Q4 | $197,446,000 | $191,758,466 | +$21,000,260 | 96.88% | 36 |
| 2024 Q3 | $175,955,750 | $168,153,997 | -$16,992,017 | 95.46% | 33 |
| 2024 Q2 | $194,425,825 | $182,795,309 | -$192,210,507 | 94.0% | 33 |
| 2024 Q1 | $398,570,793 | $378,699,477 | +$10,663,839 | 94.84% | 38 |
| 2023 Q4 | $395,569,338 | $366,703,981 | +$12,222,488 | 92.68% | 44 |
| 2023 Q3 | $382,071,649 | $345,695,382 | +$2,077,147 | 90.43% | 40 |
| 2023 Q2 | $405,789,423 | $375,881,466 | -$5,818,485 | 92.5% | 44 |
| 2023 Q1 | $403,359,913 | $371,568,705 | +$66,925,966 | 91.97% | 40 |
| 2022 Q4 | $321,157,060 | $289,900,533 | +$249,884 | 90.25% | 40 |
| 2022 Q3 | $324,906,594 | $321,281,962 | -$1,198,890 | 99.04% | 48 |
| 2022 Q2 | $318,601,745 | $330,848,058 | +$6,401,245 | 103.79% | 41 |
| 2022 Q1 | $312,741,526 | $387,225,056 | -$7,689 | 123.88% | 35 |
| 2021 Q4 | $315,869,115 | $350,807,048 | +$436,602 | 111.06% | 31 |
| 2021 Q3 | $321,906,294 | $347,129,773 | +$342,663,362 | 107.89% | 32 |